Jessica Owens joined Kleiner Perkins Caufield & Byers in 2006 to
work on investments in pandemic preparedness and bio-defense. Jessica
brings experience in global public health and infectious disease
research from four years at the Centers for Disease Control and
Prevention where she was a scientist in the Special Pathogens Branch.
Her work resulted in the discovery and demonstration of genetic shift
among Hantavirus strains. She also worked ...
more
Jessica Owens joined Kleiner Perkins Caufield & Byers in 2006 to
work on investments in pandemic preparedness and bio-defense. Jessica
brings experience in global public health and infectious disease
research from four years at the Centers for Disease Control and
Prevention where she was a scientist in the Special Pathogens Branch.
Her work resulted in the discovery and demonstration of genetic shift
among Hantavirus strains. She also worked on the development of
PCR-based diagnostic assays and conducted Hantavirus field surveillance.
Prior
to KPCB, Jessica worked in equity research covering the diagnostics
industry at Thomas Weisel Partners. She also worked in corporate
finance as part of the life sciences investment banking team at
Robertson Stephens. In addition, Jessica worked in Oncology R&D
Project Finance at Genentech.
Jessica received an MBA from
Harvard Business School, an MS from the Department of Cancer Biology at
Stanford University, and a BA in Biology from Agnes Scott College.
less
